ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 6, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-12
DOI
10.1038/s41419-019-1689-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ZEB1 inhibition sensitizes cells to the ATR inhibitor VE-821 by abrogating epithelial–mesenchymal transition and enhancing DNA damage
- (2018) Na Song et al. CELL CYCLE
- Cisplatin-DNA adduct repair of transcribed genes is controlled by two circadian programs in mouse tissues
- (2018) Yanyan Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Laminin-111 and the Level of Nuclear Actin Regulate Epithelial Quiescence via Exportin-6
- (2017) Ana Paula Zen Petisco Fiore et al. Cell Reports
- Senescence and Cancer: In the Name of Immunosuppression
- (2016) Susana Llanos et al. CANCER CELL
- Thinking in three dimensions: discovering reciprocal signaling between the extracellular matrix and nucleus and the wisdom of microenvironment and tissue architecture
- (2016) Mina J. Bissell MOLECULAR BIOLOGY OF THE CELL
- Toward a Shared Vision for Cancer Genomic Data
- (2016) Robert L. Grossman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Pathways: Targeting ATR in Cancer Therapy
- (2015) L. M. Karnitz et al. CLINICAL CANCER RESEARCH
- ATM and ATR signaling at a glance
- (2015) P. Awasthi et al. JOURNAL OF CELL SCIENCE
- Melatonergic system-based two-gene index is prognostic in human gliomas
- (2015) Gabriela S. Kinker et al. JOURNAL OF PINEAL RESEARCH
- Three-dimensional microenvironment confers enhanced sensitivity to doxorubicin by reducing p53-dependent induction of autophagy
- (2015) L R Gomes et al. ONCOGENE
- REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells
- (2015) WENJIE WANG et al. ONCOLOGY REPORTS
- ATM and ATR as therapeutic targets in cancer
- (2015) Anika Maria Weber et al. PHARMACOLOGY & THERAPEUTICS
- Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression
- (2015) Marta Giussani et al. SEMINARS IN CANCER BIOLOGY
- Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition
- (2015) Fiona K. Middleton et al. Oncotarget
- REV3L, a Promising Target in Regulating the Chemosensitivity of Cervical Cancer Cells
- (2015) Li Yang et al. PLoS One
- A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments
- (2015) Kareem N. Mohni et al. PLoS One
- Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970
- (2015) Amy B. Hall et al. Oncotarget
- Gap-filling and bypass at the replication fork are both active mechanisms for tolerance of low-dose ultraviolet-induced DNA damage in the human genome
- (2014) Annabel Quinet et al. DNA REPAIR
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- DNA repair diseases: what do they tell us about cancer and aging?
- (2014) Carlos FM Menck et al. GENETICS AND MOLECULAR BIOLOGY
- Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues
- (2012) Brendon M. Baker et al. JOURNAL OF CELL SCIENCE
- Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy
- (2012) Ajay Ummat et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
- (2012) Jan Budczies et al. PLoS One
- Both XPA and DNA polymerase eta are necessary for the repair of doxorubicin-induced DNA lesions
- (2011) Maria Carolina S. Moraes et al. CANCER LETTERS
- hMSH2 Recruits ATR to DNA Damage Sites for Activation during DNA Damage-induced Apoptosis
- (2011) Navjotsingh Pabla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Platinum resistance in breast and ovarian cancer cell lines
- (2011) Niels Eckstein JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- ATR mediates cisplatin resistance in a p53 genotype-specific manner
- (2011) N Sangster-Guity et al. ONCOGENE
- The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
- (2010) Jean-Philippe Coppé et al. Annual Review of Pathology-Mechanisms of Disease
- REV3L confers chemoresistance to cisplatin in human gliomas: The potential of its RNAi for synergistic therapy
- (2009) Huibo Wang et al. NEURO-ONCOLOGY
- ATR signaling can drive cells into senescence in the absence of DNA breaks
- (2008) L. I. Toledo et al. GENES & DEVELOPMENT
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search